SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-19-000129
Filing Date
2019-10-24
Accepted
2019-10-24 07:02:58
Documents
7
Period of Report
2019-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnca8k102419.htm 8-K 52080
2 EXHIBIT 4.1 lpcrragreement.htm EX-4.1 102405
3 EXHIBIT 5.1 ropesopinion.htm EX-5.1 6820
4 EXHIBIT 99.1 lpcpurchaseagreement.htm EX-99.1 317611
5 EXHIBIT 99.2 gnca3q19earningsprfinal201.htm EX-99.2 74195
6 genocealogosmall1.jpg GRAPHIC 16581
7 rg.jpg GRAPHIC 12228
  Complete submission text file 0001457612-19-000129.txt   588900
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 191164793
SIC: 2836 Biological Products, (No Diagnostic Substances)